DOJ Levels False Claims Act at Pharmacies to Combat Opioid Crisis

Published date14 February 2019
Law FirmDorsey & Whitney LLP
AuthorAlex Hontos,David Green,John Marti,Lauren Roso,Kirk Schuler
Subject MatterDOJ,Medicare,Criminal Prosecution,Pharmacies,Controlled Substances Act,Civil Monetary Penalty,Injunctive Relief,False Implied Certification Theory,False Claims Act (FCA),Opioid

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT